Figure 2.
Kaplan-Meier survival curves of overall survival and event-free survival according to CEBPA status in pediatric AML. Probability of (A) overall survival and (B) event-free survival of four subgroups of patients with pediatric AML, i.e. CEBPA single-mutant AML, CEBPA double-mutant AML, CEBPA wild-type non-core-binding factor (CBF) AML and CBF-AML.